Artiva Biotherapeutics (ARTV) Free Cash Flow (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Free Cash Flow of -$21.2 million for Q1 2026, down 2.53% year-over-year from -$21.8 million in Q1 2025, and down 64.7% quarter-over-quarter from -$12.9 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Free Cash Flow (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Free Cash Flow data on file, last reported at -$21.2 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$21.2 million, down 2.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$77.6 million (down 27.85% YoY), and the FY2025 annual result was -$77.1 million, down 39.94% from the prior year.
- Free Cash Flow fell to -$21.2 million in Q1 2026 per ARTV's latest filing, from -$12.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$8.9 million in Q3 2023 and troughed at -$22.4 million in Q2 2025.
- A 4-year average of -$16.0 million and a median of -$14.1 million in 2024 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 8.69% in 2025 and fell as far as 80.1% in 2025.
- A 4-year view of Free Cash Flow shows it stood at -$13.3 million in 2023, then decreased by 6.11% to -$14.1 million in 2024, then climbed by 8.69% to -$12.9 million in 2025, then plunged by 64.7% to -$21.2 million in 2026.
- Business Quant data shows ARTV's Free Cash Flow at -$21.2 million in Q1 2026, -$12.9 million in Q4 2025, and -$21.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.25 Mn |
| Mar 31, 2026 | -21.25 Mn |
| Dec 31, 2025 | -12.90 Mn |
| Dec 31, 2025 | -12.90 Mn |
| Sep 30, 2025 | -21.08 Mn |
| Sep 30, 2025 | -21.08 Mn |
| Jun 30, 2025 | -22.38 Mn |
| Jun 30, 2025 | -22.38 Mn |
| Mar 31, 2025 | -20.72 Mn |
| Mar 31, 2025 | -20.72 Mn |
| Dec 31, 2024 | -14.13 Mn |
| Dec 31, 2024 | -14.13 Mn |
| Sep 30, 2024 | -11.71 Mn |
| Sep 30, 2024 | -11.71 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Mar 31, 2024 | -15.10 Mn |
| Mar 31, 2024 | -15.10 Mn |
| Dec 31, 2023 | -13.32 Mn |
| Dec 31, 2023 | -13.32 Mn |